Table 2. Unilateral cryptorchidism (n=103) Features based on age and therapy (A-only hormonal treatment; B-hormonal first and surgery later; CX – surgery alone; TEST-Testosterone).
| < 2 years | 2-6 years | > 6 years | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Hormonal therapy | CX | Hormonal therapy | CX | Hormonal therapy | CX | ||||
| A | B | A | B | A | B | ||||
| FSH (UI/L) | 4.0 (*) | 3.5 | 5.3 (*) | 2.3 | 4.1 | 3.5 | 4.0 | 3.8 | 3.8 |
| Range | (2.5-5.4) | (1.1-7.0) | (2.5-5.7) | (2.2-8.0) | (2.0-9.5) | (3.2-6.3) | (2.5-7.6) | ||
| LH (UI/L) | 2.8 (*) | 4.2 | 2.7 (*) | 3.2 | 4.8 | 3.1 | 5.1 | 3.8 | 3.5 |
| Range | (3.3-5.6) | (3.2-3.5) | (2.9-5.9) | (2.9-3.3) | (3.2-6.1) | (2.7-5.1) | (3.3-5.8) | ||
| TEST (Ng/mL) | 4.9 (*) | 7.5 | 5.6 (*) | 6.7 | 5.9 | 4.6 | 5.2 | 5.9 | 6.0 |
| Range | (5.5-16.6) | (5.3-9.9) | (4.4-8.2) | (3.8-6.6) | (4.8-10.1) | (4.8-7.8) | (4.5-9.1) | ||
| Age at treatment (months) | 11.9 (8.6-15.7) | 18.3 (14.5-21.3) | 17.8 (17.3-20.1) | 37.2 (27.5-60) | 50.1 (34.2-54) | 36.0 (28.5-59) | 96.2 (80.5-121) | 80.9 (46.3-126) | 128.7* (87.6-142) |
| Testic. Volume | |||||||||
| Affected testis | 17.2 (11.4-23.0) | 11.2 (9.3-13.5) | 11.9 (0.1-15.0) | 15.4 (11.8-18) | 8.3*** (6.5-11.1) | 11.2 (7.1-12.4) | 11.5 (8.9-15.8) | 10.9*** (7.7-13.8) | 9.0*** (4.8-11.4) |
| Non-affected testis | 18.5 (18.0-19.0) | 15.0 (12.1-17.5) | 17.9 (12.3-33.2) | 15.3 (10.3-18) | 16.7 (13.4-20) | 14.0 (11.2-18) | 12.1 (10.6-21.6) | 14.6 (11-19.9) | 15.8 (10-22.9) |
| Patients | 2 | 5 | 3 | 4 | 20 | 4 | 16 | 30 | 19 |
(*) Only 1 case with data
* p < 0.05; ** p <0.01; *** p < 0.005; **** P <0.001